Clinical Trial Imaging Market Recent Developments, Comprehensive Analysis, Outlook and Study of Top Players 2029 – ICON, ERT, McLaren, Bioclinica, Parexel

Clinical Trial Imaging
Clinical Trial Imaging

The global Clinical Trial Imaging market research report published by market insight reports discovers the current outlook in global and key regions from the viewpoint of Major Players, Countries, Product Types, and end industries. This report studies top players in the global market and divides the Market into several parameters.

This Clinical Trial Imaging Market research report pinpoints the competitive landscape of industries to understand the competition at the International level. This report study describes the projected growth of the global market for approaching years from 2023 to 2029. This research report has been accumulated based on static and dynamic views of the businesses.

The Clinical Trial Imaging market size reached USD 1.3 billion in 2022 and is expected to reach USD 2.07 billion by 2029, growing at a CAGR of 7.5% during the forecast period.

Click Here to Get a Free Sample PDF Copy of the Latest Research on the Clinical Trial Imaging Market 2023 Before Purchase:  

The Leading Players in the Global Clinical Trial Imaging Market:

ICON, ERT, McLaren, Bioclinica, Parexel, BioTelemetry, ProScan Imaging, Imaging Endpoints, Radiant Sage, Micron, Inc., Intrinsic Imaging, Median Technologies, Cardiovascular Imaging Technologies, Banook Medical, IXICO, and Others.

Industry Development:

ICON selected by BARDA to conduct anthrax vaccine clinical trial

6 October 2022 – ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, announces that it has been selected by the US Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) in the Department of Health and Human Services (HHS), to execute an anthrax vaccine clinical trial.

ICON secures Enterprise Ireland funding to enhance digital health technology and data analytics solutions.

22 September 2021 – The Tánaiste and Minister for Enterprise, Trade and Employment, Leo Varadkar TD announced today that ICON plc (NASDAQ: ICLR), a Dublin-based global provider of drug development and commercialisation services to pharmaceutical, biotechnology and medical device industries, has been awarded €4 million in R&D support administered by Enterprise Ireland to further enhance its data solutions and decentralised clinical trial technology.

This report segments the global Clinical Trial Imaging market based on types are:

In-house Imaging Service
Central Imaging Service

Based on application, the Global Clinical Trial Imaging market is segmented into:

Pharmaceutical Companies
Biotechnology Companies
Academic Institutes

Important Features that are under Offering and Key Underlines of the Reports:

– Detailed overview of the market
– Changing market dynamics of the industry
– In-depth market segmentation by Type, Application, etc.,
– Historical, Current, and projected market size in terms of volume and value
– Recent industry trends and developments
– Competitive landscape of the Clinical Trial Imaging Market
– Strategies of key players and product offerings
– Potential and niche segments/regions exhibiting promising growth

For More Information or Query or Customization Before Buying, Visit @ 

Regional Analysis for Clinical Trial Imaging Market:

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), and market share and growth rate of the Clinical Trial Imaging Market in these regions, from 2023 to 2029 (forecast), covering North America, Europe, China, Japan, Southeast Asia, India, North America (USA, Canada, and Mexico) Europe (Germany, France, UK, Russia, and Italy) Asia–Pacific (China, Japan, Korea, India, and Southeast).

With a market share of about 40.7% in 2022 for clinical trial imaging, North America dominated the world market. This is explained by the existence of significant outsourcing firms and a rise in R&D in the area. The market in North America is expected to be driven by a number of reasons, including the rising prevalence of chronic diseases and the growing geriatric population. Most clinical trials are conducted in North America. Additionally, North America is where the majority of outsourcing occurs. Another reason why clinical trials are outsourced to other research groups is cost.

Key highlights of the report:

  • Market Performance (2017-2022)
  • Market Outlook (2023- 2029)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

“Russia-Ukraine War Impact 2022: Economic Sanctions Imposed by the United states & its Allies on the Russian Federation Negatively Affected the market

The economic sanctions imposed by the U.S. and its allies on the Russian Federation are expected to affect this industry’s growth. Furthermore, the war negatively affected the global industries leading to import and export flow disruptions. The dominance of Russia and roscosmos, a quasi-civilian space agency in the commercial space, affected alternative launch service providers in India, Japan, Europe, and the U.S. These factors negatively affected the market during the war.”

Table of Contents

– Market Summary
– Economic Impact Competition Analysis by Players
– Production, Revenue (Value) by geographical segmentation
– Clinical Trial Imaging Market Size by Type and Application
– Regional Market Status and Outlook
– Clinical Trial Imaging Market Analysis and Outlook
– Market Forecast by Region, Type, and Application
– Cost Investigation, Market Dynamics
– Marketing Strategy comprehension, Distributors and Traders
– Market Effect Factor Analysis
– Research Finding/ Conclusion
– Appendix

Finally, the Clinical Trial Imaging Market report is a believable source for gaining the market research that will exponentially accelerate your business. The report gives the principle locale, economic situations with the item value, benefit, limit, generation, supply, request, market development rate and figure, and so on. Clinical Trial Imaging industry report additionally Presents new task SWOT examination, speculation attainability investigation, and venture return investigation.   


This report can be customized to meet the client’s requirements. Please connect with our sales team (, who will ensure that you get a report that suits your needs.

Contact Us:

Irfan Tamboli (Head of Sales) – Market Insights Reports
Phone: +1704 266 3234 | +91-750-707-8687 |

Leave a Reply

Your email address will not be published. Required fields are marked *